Trademark Overview
On Wednesday, October 11, 2023, a trademark application was filed for NASADOSE with the United States Patent and Trademark Office. The USPTO has given the NASADOSE trademark a serial number of 98218716. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, September 28, 2024. This trademark is owned by Consort Medical Limited. The NASADOSE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Drug delivery devices for medical purposes, namely, inhalers sold filled with inhalable pharmaceutical preparations for the treatment of infectious, viral, bacterial, metabolic, endocrine, exocrine, muscular, skeletal, cardiovascular, respiratory, reproductive, digestive, excretory, renal, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, lymphatic, integumentary, nervous, hormonal, dermatological, psychiatric and immunological related diseases and disorders; nasal inhalers for medical purposes, sold filled with inhalable pharmaceutical preparations for treating infectious, viral, bacterial, metabolic, endocrine, exocrine, muscular, skeletal, cardiovascular, respiratory, reproductive, digestive, excretory, renal, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, lymphatic, integumentary, nervous, hormonal, dermatological, psychiatric and immunological related diseases and disorders
Medical apparatus and instruments, namely, medical apparatus and instruments for use in delivering fluid to the respiratory system; medical apparatus and instruments, namely, drug delivery devices in the nature of nasal inhalers, sold empty; medical apparatus and instruments, namely, nasal inhalation devices being inhalers for medical purposes, sold empty; structural parts and fittings for all the aforesaid goods
